GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Favipiravir Tablets 200mg
b) Favipiravir Tablets 400mg
c) Favipiravir Tablets 800mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Favipiravir Tablets 200mg
Each film-coated tablet contains:
Favipiravir………………..……..200mg
Excipients………………………..q.s.
Colours: Titanium Dioxide


b) Favipiravir Tablets 400mg
Each film-coated tablet contains:
Favipiravir………………..……..400mg
Excipients………………………..q.s.
Colours: Red oxide of Iron

c) Favipiravir Tablets 800mg
Each film-coated tablet contains:
Favipiravir………………..……..800mg
Excipients………………………..q.s.
Colours: Yellow oxide of Iron

THERAPEUTIC INDICATIONS:

Favipiravir Tablets is used in the treatment of influenza, Ebola and other pathogenic viral infections. It is also being studied to treat a number of other viral infections, including SARS-CoV-2 (Coronavirus).

DIRECTION OF USE:

As directed by the Physician

CAUTION & WARNING:

Warning: To be sold by retail on the prescription of Medical Specialist.

Warning: Do not administer the drug to women known or suspected to be pregnant
Keep out of reach and sight of children.

Swallow complete tablet, do not crush or chew.

STORAGE & DOSAGE:

Storage: Store at a temperature not exceeding 25°C. Protect from moisture.

Dosage: As directed by the Physician.

For Oral use. Read the package insert before use.

Favipiravir Tablets Technical Specifications:

Product Name:Favipiravir Tablets
Brand Name:Fabitaj
Strength:200mg, 400mg, 800mg
Dosage Form:Film-coated Tablet
Packing:10s, 17s, 34s
Route of Administration:For Oral Use only.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Antiviral, COVID-19
Indication: Favipiravir is used in the treatment of influenza, Ebola and other pathogenic viral infections. It is also being studied to treat a number of other viral infections, including SARS-CoV-2 (Coronavirus).
Storage:Store at a temperature not exceeding 25°C. Protect from moisture

GENERIC NAME OF THE MEDICINAL PRODUCT:

  1. Favipiravir Tablets 200mg
  2. Favipiravir Tablets 400mg
  3. Favipiravir Tablets 800mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Favipiravir Tablets 200mg
Each film-coated tablet contains:
Favipiravir………………..……..200mg
Excipients………………………..q.s.
Colours: Titanium Dioxide

2. Favipiravir Tablets 400mg
Each film-coated tablet contains:
Favipiravir………………..……..400mg
Excipients………………………..q.s.
Colours: Red oxide of Iron

3. Favipiravir Tablets 800mg
Each film-coated tablet contains:
Favipiravir………………..……..800mg
Excipients………………………..q.s.
Colours: Yellow oxide of Iron

THERAPEUTIC INDICATIONS:

Favipiravir is used in the treatment of influenza, Ebola and other pathogenic viral infections. It is also being studied to treat a number of other viral infections, including SARS-CoV-2 (Coronavirus).

CAUTION & WARNING:

Warning: To be sold by retail on the prescription of Medical Specialist. Do not administer the drug to women known or suspected to be pregnant.

WARNING: Male patient should use most effective contraceptive methods in sexual intercourse during and for 7 days after the end of treatment.

Keep out of reach and sight of children.

Swallow complete tablet, do not crush or chew.

STORAGE & DOSAGE:

Storage: Store at a temperature not exceeding 25°C. Protect from moisture.

Dosage: As directed by the Physician.

For Oral use. Read the package insert before use.